These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 30102624)
1. Current concept of transurethral resection of bladder cancer: from re-transurethral resection of bladder cancer to en-bloc resection. Schraml J; Silva JDC; Babjuk M Curr Opin Urol; 2018 Nov; 28(6):591-597. PubMed ID: 30102624 [TBL] [Abstract][Full Text] [Related]
2. Narrow-band imaging (NBI) and white light (WLI) transurethral resection of the bladder in the treatment of non-muscle-invasive bladder cancer. Montanari E; de la Rosette J; Longo F; Del Nero A; Laguna P Arch Ital Urol Androl; 2012 Dec; 84(4):179-83. PubMed ID: 23427740 [TBL] [Abstract][Full Text] [Related]
3. Narrow Band Imaging reduces persistence of cancer in patients with pT1 high grade bladder cancer. Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Mavilla L; Tariciotti P; Rizzo G; Fabi F; Falavolti C; Aloisi P; Vincenti G; Tema G; Lombardo R Eur J Surg Oncol; 2019 Mar; 45(3):466-470. PubMed ID: 30041940 [TBL] [Abstract][Full Text] [Related]
4. Monopolar vs. bipolar transurethral resection for non-muscle invasive bladder carcinoma: A post-hoc analysis from a randomized controlled trial. Liem EIML; McCormack M; Chan ESY; Matsui Y; Geavlete P; Choi YD; de Reijke TM; Farahat Y; Inman BA; de la Rosette JJMCH; Naito S Urol Oncol; 2018 Jul; 36(7):338.e1-338.e11. PubMed ID: 29661592 [TBL] [Abstract][Full Text] [Related]
5. The importance of transurethral resection of bladder tumor in the management of nonmuscle invasive bladder cancer: a systematic review of novel technologies. Richards KA; Smith ND; Steinberg GD J Urol; 2014 Jun; 191(6):1655-64. PubMed ID: 24518761 [TBL] [Abstract][Full Text] [Related]
6. Predictive factors of the absence of residual disease at repeated transurethral resection of the bladder. Is there a possibility to avoid it in well-selected patients? Soria F; D'Andrea D; Moschini M; Giordano A; Mazzoli S; Pizzuto G; Hurle R; Colombo R; Briganti A; Altieri V; Shariat SF; Gontero P Urol Oncol; 2020 Mar; 38(3):77.e1-77.e7. PubMed ID: 31526650 [TBL] [Abstract][Full Text] [Related]
7. Can we improve transurethral resection of the bladder tumour for nonmuscle invasive bladder cancer? Liem EI; de Reijke TM Curr Opin Urol; 2017 Mar; 27(2):149-155. PubMed ID: 27941379 [TBL] [Abstract][Full Text] [Related]
8. Reducing recurrence in non-muscle-invasive bladder cancer by systematically implementing guideline-based recommendations: effect of a prospective intervention in primary bladder cancer patients. Sörenby A; Baseckas G; Bendahl PO; Brändstedt J; Håkansson U; Nilsson S; Patschan O; Tinzl M; Wokander M; Liedberg F; Gudjonsson S Scand J Urol; 2019; 53(2-3):109-115. PubMed ID: 31064253 [No Abstract] [Full Text] [Related]
9. [Is a routine second transurethral resection of the bladder still necessary after hexaminolévulinate photodynamic diagnosis-assisted TURBT?]. Doisy L; Walz J; Fakhfakh S; Rybikowski S; Koskas Y; Gravis G; Pignot G Prog Urol; 2019; 29(6):332-339. PubMed ID: 31104952 [TBL] [Abstract][Full Text] [Related]
10. Bipolar Versus Monopolar Transurethral Resection of Nonmuscle-Invasive Bladder Cancer: A Meta-Analysis. Zhao C; Tang K; Yang H; Xia D; Chen Z J Endourol; 2016 Jan; 30(1):5-12. PubMed ID: 26413779 [TBL] [Abstract][Full Text] [Related]
11. The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging-Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging-Assisted TURBT in Primary Non-Muscle-invasive Bladder Cancer Patients: Trial Protocol and 1-year Results. Naito S; Algaba F; Babjuk M; Bryan RT; Sun YH; Valiquette L; de la Rosette J; Eur Urol; 2016 Sep; 70(3):506-15. PubMed ID: 27117749 [TBL] [Abstract][Full Text] [Related]
12. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection. Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526 [TBL] [Abstract][Full Text] [Related]
13. [Cost-effectiveness of transurethral resection of the bladder with blue light in patients with non muscle invasive bladder cancer in France]. Rouprêt M; Malavaud B; Molinier L; Leleu H; Blachier M; Marteau F Prog Urol; 2015 Apr; 25(5):256-64. PubMed ID: 25605343 [TBL] [Abstract][Full Text] [Related]
15. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience. Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376 [TBL] [Abstract][Full Text] [Related]
16. Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta/T1 patients: a randomized two-centre study. Hermann GG; Mogensen K; Carlsson S; Marcussen N; Duun S BJU Int; 2011 Oct; 108(8 Pt 2):E297-303. PubMed ID: 21414125 [TBL] [Abstract][Full Text] [Related]
17. Timing and outcomes for radical cystectomy in nonmuscle invasive bladder cancer. Zehnder P; Thalmann GN Curr Opin Urol; 2013 Sep; 23(5):423-8. PubMed ID: 23880740 [TBL] [Abstract][Full Text] [Related]
18. Could we safely omit a Repeat Transurethral Resection of the Bladder (re-TURB) after Hexaminolevulinate Photodynamic Diagnostics (PDD)-TURB? Lorusso V; Doisy L; Granata AM; Gregori A; Manfredi C; Spirito L; Sciorio C; Ciancimino LGM; Molteni S; Morelli M; Cirillo L; Napolitano L; Walz J; Pignot G Arch Ital Urol Androl; 2022 Dec; 94(4):424-427. PubMed ID: 36576467 [TBL] [Abstract][Full Text] [Related]
19. Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis? Beijert IJ; Hentschel AE; Bründl J; Compérat EM; Plass K; Rodríguez O; Subiela Henríquez JD; Hernández V; de la Peña E; Alemany I; Turturica D; Pisano F; Soria F; Čapoun O; Bauerová L; Pešl M; Bruins HM; Runneboom W; Herdegen S; Breyer J; Brisuda A; Calatrava A; Rubio-Briones J; Seles M; Mannweiler S; Bosschieter J; Kusuma VRM; Ashabere D; Huebner N; Cotte J; Contieri R; Mertens LS; Claps F; Masson-Lecomte A; Liedberg F; Cohen D; Lunelli L; Cussenot O; El Sheikh S; Volanis D; Côté JF; Rouprêt M; Haitel A; Shariat SF; Mostafid AH; Nieuwenhuijzen JA; Zigeuner R; Dominguez-Escrig JL; Hacek J; Zlotta AR; Burger M; Evert M; Hulsbergen-van de Kaa CA; van der Heijden AG; Kiemeney LALM; Soukup V; Molinaro L; Gontero P; Llorente C; Algaba F; Palou J; N'Dow J; Ribal MJ; van der Kwast TH; Babjuk M; Sylvester RJ; van Rhijn BWG Int Urol Nephrol; 2024 Apr; 56(4):1323-1333. PubMed ID: 37980689 [TBL] [Abstract][Full Text] [Related]
20. Hexaminolevulinate blue light cystoscopy (Hal) assisted transurethral resection of the bladder tumour vs white light transurethral resection of the bladder tumour in non-muscle invasive bladder cancer (NMIBC) : a retrospective analysis. Capece M; Spirito L; La Rocca R; Napolitano L; Buonopane R; Di Meo S; Sodo M; Bracale U; Longo N; Palmieri A; Fusco F; Verze P; Califano G; Crocetto F; Imbimbo C; Mirone V; Imperatore V; Creta M Arch Ital Urol Androl; 2020 Apr; 92(1):17-20. PubMed ID: 32255316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]